# Session record — cartridge design round (2026-11-11/12)

A record of how docs/09–16 came about: what the user asked, every question put to the user and the answer given,
which agent did what, what interrupted the work, and where each output is. The decisions themselves are fixed in
docs/16 §2 and CLAUDE.md; this file is the trail behind them. It contains no new technical claims.

## 1. The request

> "Let's design a microfluidic chip that handles everything after the SM-FL. Again, you are an orchestrator that
> manages opus agents to do this. Interview me."

Later requests in the same session: "Build a summary slide deck of this session. A picture says a 1000 words.
Interview me."; "move all of this into the main repo."; "Everything from the entire session."

## 2. Interview — every question and answer

### Round 1 (before any agent started)

| # | Question | Answer |
|---|---|---|
| 1 | What should the chip physically contain? | Path + valves + reagents (a cartridge; only pressure/pump sources, magnet and potentiostat external) |
| 2 | How does the chip relate to the existing design (docs/05) and bench plan (docs/06)? | Second generation: the tubing build is still built first |
| 3 | Which assay format should the chip be designed around? | Reopen the choice |
| 4 | How will the chip be made? | Let agents recommend |

### Round 2

| # | Question | Answer |
|---|---|---|
| 5 | What is the chip's lifetime? | Let agents recommend |
| 6 | What may the chip rely on outside itself for moving liquid and actuating? | Docking station free: it may contain anything; only the consumable must be simple |
| 7 | Electrochemical detection on the chip: which constraint applies? | Agents choose |
| 8 | How far should this round go, and when do you want to be consulted? | Concept + model + decision, with one checkpoint after the candidates are defined |

### Round 3

| # | Question | Answer |
|---|---|---|
| 9 | How many determinations should one load of on-board reagents cover? | Agents propose |
| 10 | May the chip run several determinations in parallel? | Agents evaluate |
| 11 | Do the success criteria and fixed decisions apply unchanged? | Unchanged |

### Checkpoint after the candidates (docs/12)

| # | Question | Answer |
|---|---|---|
| 12 | Which candidate goes forward? (recommended: A, B as fallback) | "Keep C alive too" — read as: A to detailed design, B documented fallback, C carried forward with work on its carry-over and valve problems |
| 13 | Should pre-electrolysis of the substrate go into the gen-1 bench plan now? | Add bench test only (became E1.2b) |
| 14 | Where should the reagents live for an 8-hour block? | Agents compare both (all on the card vs bead stock in the dock) |
| 15 | How much should the simulation be extended before the decision document? | Estimates are enough (no model extension this round) |

### After the adversarial review (docs/15)

| # | Question | Answer |
|---|---|---|
| 16 | The design ended with no reagent supplied on the card. Which do you want? | Accept dock supply (supersedes answer 1 for reagents) |
| 17 | A 16-run card takes 9.5 h and the margin is about 1 min. How to handle this? | Cap the card at about 14 determinations and recover at least 3 min of margin |
| 18 | The autosampler's nominal carry-over alone uses the 1e-4 budget. Which rule? | Keep 1e-4 and add a mandatory cleaning cycle and blank check after any result above 100 pg/mL |
| 19 | Approve the read-background test on a catalogue die before G1? | Approve the test (became M5a) |

### Slide deck interview

| # | Question | Answer |
|---|---|---|
| 20 | Who is the deck for? | Technical colleagues |
| 21 | What should the deck cover? | The cartridge round, and the process as well |
| 22 | Which pictures matter most? | All four: cartridge A cross-section and plan, assay cycle timeline, three candidates side by side, performance and risk charts |
| 23 | How long, and how used? | About 18 slides, read alone |

### Moving the work into main

| # | Question | Answer |
|---|---|---|
| 24 | How do you want it brought into main? | Merge directly into main (explicit permission to push to main) |

## 3. Agent tasks

All agents ran on the Opus model, in the background, each writing one document and reporting a summary. The
orchestrator checked, committed and pushed each piece.

| Phase | Agent task | Output | Lines |
|---|---|---|---|
| 1 | Requirements and interface specification from the repo; modelling map | docs/09 | 595 |
| 1 | Literature survey | docs/10 | 381 |
| 1 | Fabrication, component and vendor survey | docs/11 | 555 |
| 2 | Architect: three candidate architectures with nearest-model estimates | docs/12 | 1103 (incl. the later corrections box) |
| 3 | Detailed design of cartridge A | docs/13 (first version) | 1066 |
| 3 | Alternatives: make C viable; fallback dossier for B | docs/14 (first version) | 687 |
| 3 | Add the pre-electrolysis bench test to the gen-1 plan | docs/06 E1.2b, docs/07, template, gates.yaml | – |
| 4 | Adversarial review of docs/09–14 and E1.2b | docs/15 | 541 (incl. the later resolution section) |
| 5 | Revise design A after the review and the user's four decisions | docs/13 Revision B | 1350 |
| 5 | Apply the review to docs/12 and docs/14 | docs/12 corrections box, docs/14 revised | 889 (docs/14) |
| 5 | Decision document, resolution of findings, M5a in the bench plan, CLAUDE.md | docs/16, docs/15 §7, docs/06, docs/07 | 344 (docs/16) |

Eleven agent tasks. The slide deck and this record were written by the orchestrator directly.

## 4. Orchestrator interventions

* **E1.2b kept strictly informational.** The bench-plan agent had allowed E1.2b's post-electrolysis hydrolysis rate
  to replace the E1.2 value as a G1 input when E1.2 could not resolve it. Because the user asked for a test only and
  the G1 rule is fixed before data, this was changed to a consistency check that is not entered for G1a or G1.
* **Guard-cell inconsistency passed to the review.** The bench-plan agent noticed that the commercial coulometric
  cell named in docs/12 has a collection efficiency of 0.95 (about 5 % escape per pass, not 1 %) and a minimum flow
  above the gen-1 substrate fill flow; the reviewer was told to follow it through all documents (finding S8).
* **Reviewer's own redo checked.** The docs/14 correction agent found the reviewer's redo of the C′ carry-over table
  slightly optimistic (P 0.152 vs 0.10 at a residual of 1e-4 after a 1000 pg/mL predecessor); both are recorded in
  docs/15 §7 and 0.10 is used.
* **Deck layout.** Rendering the deck showed one table running past the margin and a chart label overlapping a bar
  label; both were fixed before the deck was committed.

## 5. Interruptions

The agents hit the 5-hour usage limit three times: all three phase-1 agents before writing anything; all three
phase-3 agents part-way; the decision-document agent while still reading. Each time the agents were resumed from
their saved transcripts when the limit reset and told to write to disk early. The session's worker process also
restarted several times; no work was lost. Because of the stop hook's rule that the tree must be committed, some
commits hold work in progress (marked as such in the list below).

Tool limits that left gaps in the documents: the fabrication agent's web-search quota ran out and one foundry site
refused requests (gaps listed in docs/11 §8); the literature agent checked abstracts only, not full texts; the
Consensus search tool reached 96 % of its monthly quota.

## 6. Commits of the session

| Commit | Subject |
|---|---|
| `15bead7` | Add chip generation phase 1 surveys (fabrication complete; requirements and literature in progress) |
| `499a5d0` | Complete chip requirements and interface specification (docs/09) |
| `222428c` | Add chip candidate architectures (docs/12): three candidates, nearest-model estimates, checkpoint decisions |
| `6f3ea10` | Work in progress: chip alternatives B/C draft and pre-electrolysis bench test (agents still extending) |
| `20393ee` | Work in progress: phase 3 chip documents and bench-plan edits (agents still extending) |
| `514d4fe` | Add E1.2b pre-electrolysis bench test (informational, not a G1a/G1 input) |
| `d0cc22c` | Complete chip alternatives B and C (docs/14); design A draft in progress (docs/13) |
| `0958c5f` | Complete detailed design of cartridge A (docs/13) |
| `9991148` | Add adversarial review of the chip design (docs/15): 2 blockers, 11 significant findings |
| `0c71ba3` | Apply review findings to docs/12 (corrections box) and docs/14 (B and C' re-derived) |
| `bac7000` | Revise cartridge A design after review (docs/13 Revision B) |
| `e8de497` | Add cartridge decision document (docs/16) and close the design round |
| `20f2c4d` | Add cartridge design round slide deck (standalone HTML, sources, build script for both decks) |

Plus one merge of main into the working branch (bringing in the earlier in silico presentation) and the commit that
adds this record and `scripts/chip_round/`. Branch `claude/sleepy-mayer-hwypo0` was fast-forwarded into `main`
on 2026-11-12 with the user's permission (answer 24).

## 7. Where everything is

| What | Where |
|---|---|
| Requirements, literature, fabrication | docs/09, docs/10, docs/11 |
| Candidates (with corrections box) | docs/12 |
| Cartridge A, Revision B | docs/13 |
| Alternatives B and C′ (revised) | docs/14 |
| Review and resolution of findings | docs/15 (§7) |
| Decision, authoritative comparison, gates, open questions | docs/16 (§8 for the open questions) |
| Added bench experiments E1.2b and M5a | docs/06, docs/07, `automation/templates/`, `automation/config/gates.yaml` |
| Agents' working scripts and outputs | `scripts/chip_round/` (README there; scripts do not run as they stand) |
| Slide deck, standalone and sources | `docs/presentation/cartridge_round.html`, `docs/presentation/source_cartridge/` |
| Slide deck, published copy (private to the owner until shared) | https://claude.ai/artifact/U4sqXYGHGG6GYKU5eNzcMU |

## 8. What is not in the repository

* The agents' full transcripts (searches, intermediate reasoning, discarded drafts). Only their documents, their
  summaries as relayed in the session, and their scripts and outputs are kept.
* Vendor PDFs and PubMed abstract texts the agents downloaded (third-party material; the URLs, DOIs and PMIDs are in
  docs/10, docs/11, docs/14 and `scripts/chip_round/literature_docs10/`).
* The scratch copies of the repository used for model runs, and a 1 MB magnet field grid that `mag_b.py` regenerates.
* The first versions of docs/13 and docs/14 as separate files: they are in the git history (commits "Complete
  detailed design of cartridge A" and "Complete chip alternatives B and C").
